Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Generic protein (with groove 2)
[{"image":"https://icons.cdn.biorender.com/w75xh75/5c093c665c22a91200d6601d/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c093c665c22a91200d6601d/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa279/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa279/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa277/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa277/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa275/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa275/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa273/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa273/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa271/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa271/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa26f/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa26f/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa26d/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa26d/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa26b/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa26b/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa269/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa269/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa267/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa267/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa265/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa265/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa263/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa263/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa261/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa261/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa25f/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa25f/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa25d/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa25d/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa25b/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa25b/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa259/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa259/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa257/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa257/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa255/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa255/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa253/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa253/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa251/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa251/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa24f/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa24f/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa24d/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa24d/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa24b/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa24b/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa249/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa249/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e2afe244f2cc000281aa247/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e2afe244f2cc000281aa247/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e19/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e19/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e18/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e18/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e17/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e17/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e16/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e16/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e15/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e15/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e14/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e14/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e13/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e13/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e12/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e12/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e11/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e11/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e10/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e10/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e0f/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e0f/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e0e/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e0e/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e0d/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e0d/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e0c/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e0c/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e0b/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e0b/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e0a/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e0a/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e09/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e09/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e08/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e08/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e07/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e07/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e06/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e06/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e05/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e05/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e04/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e04/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e03/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e03/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e02/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e02/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e01/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e01/5c093bdf5c22a91200d6601c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f500b11e47b4e0027829e00/5c093bdf5c22a91200d6601c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f500b11e47b4e0027829e00/5c093bdf5c22a91200d6601c.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
philadelphia chromosome,philadelphia translocation,bcr-abl,p,abl gene,tyrosine kinase inhibitor,tki,cml,chronic myelogenous leukemia,protein
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
